Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 67363 

The company plans to bulk 

manufacture the listed controlled 

substances for DEA exempted certified 

reference materials. In-house synthesis 

gives access to compounds that are 

difficult to source. No other activities 

for these drug codes are authorized for 

this registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–21401 Filed 9–28–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1277] 

Importer of Controlled Substances 

Application: Restek Corporation 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Restek Corporation has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 30, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 30, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on August 24, 2023, Restek 

Corporation, 110 Benner Circle, 

Bellefonte, Pennsylvania 16823–8433, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug code Schedule 

Amineptine ....................................................................................................................................................................... 1219 I 

Mesocarb ......................................................................................................................................................................... 1227 I 

3-Fluoro-N-methylcathinone (3–FMC) ............................................................................................................................. 1233 I 

Cathinone ........................................................................................................................................................................ 1235 I 

Methcathinone ................................................................................................................................................................. 1237 I 

4-Fluoro-N-methylcathinone (4–FMC) ............................................................................................................................. 1238 I 

Para-Methoxymethamphetamine (PMMA), 1-(4–1245 I N methoxyphenyl)-N-methylpropan-2-amine .......................... 1245 I 

Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone ..................................................................................................................... 1248 I 

4-Methyl-N-ethylcathinone (4–MEC) ............................................................................................................................... 1249 I 

Naphyrone ....................................................................................................................................................................... 1258 I 

N-Ethylamphetamine ....................................................................................................................................................... 1475 I 

Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- 1478 I N amine) ...................................................................... 1478 I 

N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I 

Fenethylline ..................................................................................................................................................................... 1503 I 

Aminorex .......................................................................................................................................................................... 1585 I 

4-Methylaminorex (cis isomer) ........................................................................................................................................ 1590 I 

4,4′-Dimethylaminorex ..................................................................................................................................................... 1595 I 

Methylphenidate .............................................................................................................................................................. 1724 I 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Methaqualone .................................................................................................................................................................. 2565 I 

Mecloqualone .................................................................................................................................................................. 2572 I 

JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .................................................................................................. 6250 I 

SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................ 7008 I 

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7010 I 

5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................ 7011 I 

AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..................... 7012 I 

FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ............................................... 7014 I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ...................................................................................................................... 7019 I 

MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...................... 7020 I 

FUB–AMB, MMB- FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- 

methylbutanoate).

7021 I 

AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................................... 7023 I 

THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................. 7024 I 

5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ........................ 7025 I 

AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............... 7031 I 

MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........ 7032 I 

5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .............................................. 7033 I 

5F–ADB, 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...... 7034 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................. 7035 I

5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......................... 7036 I 

5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) .............................. 7041 I 


lotter on DSK11XQN23PROD with NOTICES1
67364 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 

Controlled substance Drug code Schedule 

MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- 

dimethylbutanoate).

7042 I 

4F–MDMB–BINACA (4F–MDMB–BUTINACA or methyl 2- (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- 

dimethylbutanoate) 7043 I N.

7043 I 

MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ........ 7044 I 

FUB–AKB48, FUB–APINACA, AKB48 N-(4–FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole3-carboximide).7047 I 

APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ............................................................ 7048 I 

5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .................................. 7049 I 

JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .................................................................................................. 7081 I 

5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) .................... 7083 I 

5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ............... 7085 I 

4–CN–CUML–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 

(1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).

7089 I 

SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ................................................................... 7104 I 

JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I 

JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..................................................................................................... 7122 I 

UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ................................................................. 7144 I 

JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7173 I 

JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .......................................................................................... 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I 

JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I 

NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate .......................................................... 7221 I 

PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ................................................................................................. 7222 I 

5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................ 7225 I 

4-methyl-alpha-ethylaminopentiophenone (4–MEAP) 7245 I N 4–MEAP ...................................................................... 7245 I 

N-ethylhexedrone 7246 I N ............................................................................................................................................. 7246 I 

Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I 

Ibogaine ........................................................................................................................................................................... 7260 I 

2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine) ....................................................................... 7286 I 

CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................ 7297 I 

CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .......................................... 7298 I 

Lysergic acid diethylamide .............................................................................................................................................. 7315 I 

2C–T–7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ............................................................................................... 7348 I 

Marihuana Extract ........................................................................................................................................................... 7350 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Parahexyl ......................................................................................................................................................................... 7374 I 

Mescaline ......................................................................................................................................................................... 7381 I 

2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) .......................................................................................... 7385 I 

3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I 

2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I 

JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 7398 I 

2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 7399 I 

3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

4-Methoxyamphetamine .................................................................................................................................................. 7411 I 

Peyote .............................................................................................................................................................................. 7415 I 

5-Methoxy-N–N-dimethyltryptamine ................................................................................................................................ 7431 I 

Alpha-methyltryptamine ................................................................................................................................................... 7432 I 

Bufotenine ........................................................................................................................................................................ 7433 I 

Diethyltryptamine ............................................................................................................................................................. 7434 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

Psilocybin ......................................................................................................................................................................... 7437 I 

Psilocyn ........................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I 

4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ............................................................................................ 7443 I 

4 ́-methyl-alpha-pyrrolidinohexiophenone (MPHP) .......................................................................................................... 7446 I 

N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I 

1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. 7473 I 

N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ 7482 I 

N-Methyl-3-piperidyl benzilate ......................................................................................................................................... 7484 I 

N-Benzylpiperazine .......................................................................................................................................................... 7493 I 

4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ..................................................................................................... 7498 I 

2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .................................................................................................. 7508 I 

2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ..................................................................................................... 7509 I 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 67365 

Controlled substance Drug code Schedule 

2C–H 2-(2,5-Dimethoxyphenyl) ethanamine) .................................................................................................................. 7517 I 

2C–I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ......................................................................................................... 7518 I 

2C–C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ................................................................................................... 7519 I 

2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) .................................................................................................... 7521 I 

2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ............................................................................................. 7524 I 

2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) .................................................................................... 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I 

25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .................................................... 7536 I 

25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .................................................... 7537 I 

25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ......................................................... 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I 

Butylone ........................................................................................................................................................................... 7541 I 

Pentylone ......................................................................................................................................................................... 7542 I 

N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ..................................................... 7543 I 

alpha-pyrrolidinohexanophenone (a-PHP) ...................................................................................................................... 7544 I 

alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... 7546 I 

Ethylone ........................................................................................................................................................................... 7547 I 

alpha-pyrrolidinoheptaphenone (PV8) ............................................................................................................................. 7548 I 

AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ................................................................................................... 7694 I 

Acetyldihydrocodeine ....................................................................................................................................................... 9051 I 

Benzylmorphine ............................................................................................................................................................... 9052 I 

Codeine-N-oxide .............................................................................................................................................................. 9053 I 

Cyprenorphine ................................................................................................................................................................. 9054 I 

Desomorphine ................................................................................................................................................................. 9055 I 

Etorphine (except HCl) .................................................................................................................................................... 9056 I 

Codeine methylbromide ................................................................................................................................................... 9070 I 

Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4–4l)1,3-dihydro-2H-benzo[d]imidazol-2-one) ................................. 9098 I 

Dihydromorphine ............................................................................................................................................................. 9145 I 

Difenoxin .......................................................................................................................................................................... 9168 I 

Heroin .............................................................................................................................................................................. 9200 I 

Hydromorphinol ............................................................................................................................................................... 9301 I 

Methyldesorphine ............................................................................................................................................................ 9302 I 

Methyldihydromorphine ................................................................................................................................................... 9304 I 

Morphine methylbromide ................................................................................................................................................. 9305 I 

Morphine methylsulfonate ............................................................................................................................................... 9306 I 

Morphine-N-oxide ............................................................................................................................................................ 9307 I 

Myrophine ........................................................................................................................................................................ 9308 I 

Nicocodeine ..................................................................................................................................................................... 9309 I 

Nicomorphine ................................................................................................................................................................... 9312 I 

Normorphine .................................................................................................................................................................... 9313 I 

Pholcodine ....................................................................................................................................................................... 9314 I 

Thebacon ......................................................................................................................................................................... 9315 I 

Acetorphine ...................................................................................................................................................................... 9319 I 

Drotebanol ....................................................................................................................................................................... 9335 I 

U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .............................................................. 9547 I 

AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. 9551 I 

MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .................................................................................................. 9560 I 

Acetylmethadol ................................................................................................................................................................ 9601 I 

Allylprodine ...................................................................................................................................................................... 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... 9603 I 

Alphameprodine ............................................................................................................................................................... 9604 I 

Alphamethadol ................................................................................................................................................................. 9605 I 

Benzethidine .................................................................................................................................................................... 9606 I 

Betacetylmethadol ........................................................................................................................................................... 9607 I 

Betameprodine ................................................................................................................................................................ 9608 I 

Betamethadol ................................................................................................................................................................... 9609 I 

Betaprodine ..................................................................................................................................................................... 9611 I 

Clonitazene ...................................................................................................................................................................... 9612 I 

Dextromoramide .............................................................................................................................................................. 9613 I 

Isotonotazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) ............................ 9614 I 

Diampromide ................................................................................................................................................................... 9615 I 

Diethylthiambutene .......................................................................................................................................................... 9616 I 

Dimenoxadol .................................................................................................................................................................... 9617 I 

Dimepheptanol ................................................................................................................................................................. 9618 I 

Dimethylthiambutene ....................................................................................................................................................... 9619 I 

Dioxaphetyl butyrate ........................................................................................................................................................ 9621 I 

Dipipanone ....................................................................................................................................................................... 9622 I 

Ethylmethylthiambutene .................................................................................................................................................. 9623 I 

Etonitazene ...................................................................................................................................................................... 9624 I 

Etoxeridine ....................................................................................................................................................................... 9625 I 

Furethidine ....................................................................................................................................................................... 9626 I 

Hydroxypethidine ............................................................................................................................................................. 9627 I 

Ketobemidone .................................................................................................................................................................. 9628 I 


lotter on DSK11XQN23PROD with NOTICES1
67366 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 

Controlled substance Drug code Schedule 

Levomoramide ................................................................................................................................................................. 9629 I 

Levophenacylmorphan .................................................................................................................................................... 9631 I 

Morpheridine .................................................................................................................................................................... 9632 I 

Noracymethadol ............................................................................................................................................................... 9633 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Normethadone ................................................................................................................................................................. 9635 I 

Norpipanone .................................................................................................................................................................... 9636 I 

Phenadoxone ................................................................................................................................................................... 9637 I 

Phenampromide .............................................................................................................................................................. 9638 I 

Phenoperidine .................................................................................................................................................................. 9641 I 

Piritramide ........................................................................................................................................................................ 9642 I 

Proheptazine .................................................................................................................................................................... 9643 I 

Properidine ...................................................................................................................................................................... 9644 I 

Racemoramide ................................................................................................................................................................ 9645 I 

Trimeperidine ................................................................................................................................................................... 9646 I 

Phenomorphan ................................................................................................................................................................ 9647 I 

Propiram .......................................................................................................................................................................... 9649 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 9661 I 

1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .............................................................................................................. 9663 I 

Tilidine ............................................................................................................................................................................. 9750 I 

Butonitazene .................................................................................................................................................................... 9751 I 

Lunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro1H-benzimidazol-1-yl)ethan-1- amine) ......................................... 9756 I 

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine ................................... 9757 I 

N-pyrrolidino etonitazene; etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1Hbenzimidazole) ..... 9758 I 

Protonitazene (N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) ................................. 9759 I 

Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 1H-benzimidazol-1- yl)ethan-1-amine) .................................... 9764 I 

Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)- 1Hbenzimidazol-1-yl)-N,N-diethylethan-1- amine) ............................ 9765 I 

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ................................................................................. 9811 I 

Para-Fluorofentanyl ......................................................................................................................................................... 9812 I 

3-Methylfentanyl .............................................................................................................................................................. 9813 I 

Alpha-methylfentanyl ....................................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ............................................................................................................................................. 9815 I 

N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ....................................................................................... 9816 I 

Para-Methylfentanyl (N-(4-methylphenyl)-N-(1- phenethylpiperidin-4-yl)propionamide; also known as 4- 

methylfentanyl).

9817 I 

4’-Methyl acetyl fentanyl (N-(1-(4- methylphenethyl)piperidin-4-yl)-N-phenylacetamide) ............................................... 9819 I 

Ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2- methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) ......... 9820 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... 9821 I 

Butyryl Fentanyl ............................................................................................................................................................... 9822 I 

Para-fluorobutyryl fentanyl ............................................................................................................................................... 9823 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................... 9824 I 

2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ......................................................................................... 9825 I 

Para-chloroisobutyryl fentanyl ......................................................................................................................................... 9826 I 

Isobutyryl fentanyl ............................................................................................................................................................ 9827 I 

Beta-hydroxyfentanyl ....................................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ 9831 I 

Alpha-methylthiofentanyl ................................................................................................................................................. 9832 I 

3-Methylthiofentanyl ......................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. 9834 I 

Thiofentanyl ..................................................................................................................................................................... 9835 I 

Beta-hydroxythiofentanyl ................................................................................................................................................. 9836 I 

Para-methoxybutyryl fentanyl .......................................................................................................................................... 9837 I 

Ocfentanil ......................................................................................................................................................................... 9838 I 

Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylthiophene-2-carboxamide; also known as 2- thiofuranyl 

fentanyl; thiophene fentanyl).

9839 I 

Valeryl fentanyl ................................................................................................................................................................ 9840 I 

Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylbenzamide; also known as benzoyl fentanyl) .......................... 9841 I 

Beta’-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- diphenylpropanamide; also known as b’-phenyl fentanyl; 3- 

phenylpropanoyl fentanyl).

9842 I 

N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .......................................................................... 9843 I 

Crotonyl fentanyl ((E–N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) ................................................................ 9844 I 

Cyclopropyl Fentanyl ....................................................................................................................................................... 9845 I 

Cyclopentyl fentanyl ........................................................................................................................................................ 9847 I 

Ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl)acetamide; also known as 2- methyl 

acetylfentanyl).

9848 I 

Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ..................................................................................... 9850 I 

Fentanyl carbamate (ethyl (1-phenethylpiperidin-4- yl)(phenyl)carbamate) ................................................................... 9851 I 

Ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)acrylamide) ............................................. 9852 I 

Ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide) ................................ 9853 I 

Para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)furan-2-carboxamide) .......................... 9854 I 

2’-Fluoro ortho-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known 

as 2’-fluoro 2- fluorofentanyl).

9855 I 

Beta-Methyl fentanyl (N-phenyl-N-(1-(2- phenylpropyl)piperidin-4-yl)propionamide; also known as b-methyl fentanyl) 9856 I 

Zipeprol ............................................................................................................................................................................ 9873 I 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 67367 

Controlled substance Drug code Schedule 

Amphetamine ................................................................................................................................................................... 1100 II 

Methamphetamine ........................................................................................................................................................... 1105 II 

Lisdexamfetamine ............................................................................................................................................................ 1205 II 

Phenmetrazine ................................................................................................................................................................. 1631 II 

Amobarbital ...................................................................................................................................................................... 2125 II 

Pentobarbital .................................................................................................................................................................... 2270 II 

Secobarbital ..................................................................................................................................................................... 2315 II 

Glutethimide ..................................................................................................................................................................... 2550 II 

Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration 7365 II 

Nabilone ........................................................................................................................................................................... 7379 II 

1-Phenylcyclohexylamine ................................................................................................................................................ 7460 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

ANPP (4-Anilino-N-phenethyl-4-piperidine) ..................................................................................................................... 8333 II 

Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) ................................................................................................. 8366 II 

Phenylacetone ................................................................................................................................................................. 8501 II 

1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ 8603 II 

Alphaprodine .................................................................................................................................................................... 9010 II 

Anileridine ........................................................................................................................................................................ 9020 II 

Coca Leaves .................................................................................................................................................................... 9040 II 

Cocaine ............................................................................................................................................................................ 9041 II 

Codeine ........................................................................................................................................................................... 9050 II 

Etorphine HCl .................................................................................................................................................................. 9059 II 

Dihydrocodeine ................................................................................................................................................................ 9120 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Diphenoxylate .................................................................................................................................................................. 9170 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Ethylmorphine .................................................................................................................................................................. 9190 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Levomethorphan .............................................................................................................................................................. 9210 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Isomethadone .................................................................................................................................................................. 9226 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine intermediate-A .............................................................................................................................................. 9232 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Meperidine intermediate-C .............................................................................................................................................. 9234 II 

Metazocine ...................................................................................................................................................................... 9240 II 

Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl 

{time})amine fumarate).

9245 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Metopon ........................................................................................................................................................................... 9260 II 

Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 

Morphine .......................................................................................................................................................................... 9300 II 

Oripavine ......................................................................................................................................................................... 9330 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Dihydroetorphine ............................................................................................................................................................. 9334 II 

Opium, raw ...................................................................................................................................................................... 9600 II 

Opium extracts ................................................................................................................................................................ 9610 II 

Opium fluid extract .......................................................................................................................................................... 9620 II 

Opium tincture ................................................................................................................................................................. 9630 II 

Opium, powdered ............................................................................................................................................................ 9639 II 

Opium, granulated ........................................................................................................................................................... 9640 II 

Levo-alphacetylmethadol ................................................................................................................................................. 9648 II 

Opium poppy ................................................................................................................................................................... 9650 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Poppy Straw Concentrate ............................................................................................................................................... 9670 II 

Phenazocine .................................................................................................................................................................... 9715 II 

Thiafentanil ...................................................................................................................................................................... 9729 II 

Piminodine ....................................................................................................................................................................... 9730 II 

Racemethorphan ............................................................................................................................................................. 9732 II 

Racemorphan .................................................................................................................................................................. 9733 II 

Alfentanil .......................................................................................................................................................................... 9737 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

Bezitramide ...................................................................................................................................................................... 9800 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

Moramide-intermediate .................................................................................................................................................... 9802 II 


lotter on DSK11XQN23PROD with NOTICES1
67368 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 

The company plans to import 

analytical reference standards for 

distribution to its customers for research 

and analytics purposes. Placement of 

these drug codes onto the company’s 

registration does not translate into 

automatic approval of subsequent 

permit applications to import controlled 

substances. Approval of permit 

applications will occur only when the 

registrant’s business activity is 

consistent with what is authorized in 21 

U.S.C. 952(a)(2). Authorization will not 

extend to the import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–21404 Filed 9–28–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1274] 

Importer of Controlled Substances 

Application: Cambridge Isotope 

Laboratories, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cambridge Isotope 

Laboratories, Inc. has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 30, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 30, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on August 25, 2023, 

Cambridge Isotope Laboratories, Inc. 50 

Frontage Road, Andover, Massachusetts 

01810–5413, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid.

2010 I 

Tetrahydrocannabinols 7370 I 

Morphine ....................... 9300 II 

The company plans to import the 

listed controlled substances for 

preparation of analytical standards and 

formulations. In reference to drug codes 

7370 (Tetrahydrocannabinols), the 

company plans to import a synthetic 

Tetrahydrocannabinol. No other 

activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–21402 Filed 9–28–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF LABOR 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; 

Formaldehyde Standard 

ACTION: Notice of availability; request 

for comments. 

SUMMARY: The Department of Labor 

(DOL) is submitting this Occupational 

Safety & Health Administration (OSHA)- 

sponsored information collection 

request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995 

(PRA). Public comments on the ICR are 

invited. 

DATES: The OMB will consider all 

written comments that the agency 

receives on or before October 30, 2023. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

Comments are invited on: (1) whether 

the collection of information is 

necessary for the proper performance of 

the functions of the Department, 

including whether the information will 

have practical utility; (2) the accuracy of 

the agency’s estimates of the burden and 

cost of the collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

ways to enhance the quality, utility and 

clarity of the information collection; and 

(4) ways to minimize the burden of the 

collection of information on those who 

are to respond, including the use of 

automated collection techniques or 

other forms of information technology. 

FOR FURTHER INFORMATION CONTACT: 

Nicole Bouchet by telephone at 202– 

693–0213, or by email at DOL_PRA_

PUBLIC@dol.gov. 

SUPPLEMENTARY INFORMATION: The 

Formaldehyde Standard and its 

collections of information are designed 

to provide protection for workers from 

the adverse health effects associated 

with occupational exposure to 

formaldehyde. The Standard requires 

employers to monitor worker exposure 

and provide notification to workers of 

their exposure. Employers are required 

to make available medical surveillance 

to workers. For additional substantive 

information about this ICR, see the 

related notice published in the Federal 

Register on June 28, 2023 (88 FR 41984). 

This information collection is subject 

to the PRA. A Federal agency generally 

cannot conduct or sponsor a collection 

of information, and the public is 

generally not required to respond to an 

information collection, unless the OMB 

approves it and displays a currently 

valid OMB Control Number. In addition, 

notwithstanding any other provisions of 


lotter on DSK11XQN23PROD with NOTICES1